This invention provides a method of treating a human subject suffering from a CB1 receptor related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.
Martino, G., Centonze, D. (2012). Laquinimod for treatment of cannabinoid receptor type 1(cb1) mediated disorders.
Laquinimod for treatment of cannabinoid receptor type 1(cb1) mediated disorders
CENTONZE, DIEGO
2012-08-13
Abstract
This invention provides a method of treating a human subject suffering from a CB1 receptor related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Brevetto US20140045887 - Laquinimod for treatment of cannabinoid receptor type 1(cb1) mediated disorders - Google Brevetti.pdf
non disponibili
Dimensione
362.54 kB
Formato
Adobe PDF
|
362.54 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
